Anemia, Biermer’s: A blood disorder caused by a lack of vitamin B12. Patients who have this disorder do not produce the substance in the stomach that allows the body to absorb vitamin B12. This substance is called intrinsic factor (IF).
Biermer’s anemia, better known as pernicious anemia (PA), is characterized by the presence in the blood of large, immature, nucleated cells (megaloblasts) that are forerunners of red blood cells. (Red blood cells, when mature, have no nucleus). It is thus a type of megaloblastic anemia.
Pernicious anemia (PA) was first described (although not by that name) in 1855 by the English physician Thomas Addison. He called it an invariably fatal “idiopathic anemia.” The “idiopathic” was a frank admission that the cause of this illness was wholly unknown. The name “pernicious anemia” was coined in 1872 by the German physician Anton Biermer whose description of the disease was superior to that of Addison. The studies of George H. Whipple on the effects of feeding liver in anemia followed by those of George R. Minot and Wm. P. Murphy on the effects of feeding liver specifically in pernicious anemia (PA) led to the cure of PA and to their receiving the Nobel Prize in 1934.
Nowadays PA is an unpernicious anemia. It is simply treated with vitamin B12. The vitamin B12 has to be administered by injection (parenterally) because people with PA do not have IF (or an effective form of IF) and so cannot absorb vitamin B12 taken by mouth.
There is some evidence that PA may be genetic although its mode of inheritance is poorly documented. There is a congenital form of PA due to defect of IF that is clearly inherited as an autosomal recessive trait with the affected child having received two copies of the gene, one from each parent. The IF gene itself has been localized to human chromosome 11.
The word “pernicious” means highly injurious, destructive, or deadly. “Pernicious” comes from the Latin root “nex” meaning “violent death.” Pernicious anemia was once quite deadly. Today it fortunately is not.
PA has also been called addisonian anemia and Addison’s anemia.
- Anemia, Cooley's
Anemia, Cooley’s: Better known today as thalassemia (or as beta thalassemia or thalassemia major). The clinical picture of this important type of anemia was first described in 1925 by the pediatrician Thomas Benton Cooley. Another name for the disease is Mediterranean anemia. The name thalassemia was coined by the Nobel Prize winning pathologist George Whipple […]
- Anemia, Fanconi
Anemia, Fanconi: A rare, inherited disease that adversely affects all the elements of bone marrow and is associated with malformations of the heart, kidney, and limbs, as well as pigmentary changes of the skin. Fanconi anemia predisposes a person to cancer, particularly to a disturbance of bone marrow growth called myelodysplasia and to acute myeloid […]
- Anemia, iron deficiency
Anemia, iron deficiency: Anemia due to inadequate iron. Iron is necessary to make hemoglobin, the molecule in red blood cells that is responsible for the transport of oxygen. In iron deficiency anemia, the red cells are small and pale. Characteristic features of iron deficiency anemia in children include failure to thrive and increased infections. Iron […]
- Anemia, Mediterranean
Anemia, Mediterranean: Better known today as thalassemia (or as beta thalassemia or thalassemia major). The clinical picture of this important type of anemia was first described in 1925 by the pediatrician Thomas Benton Cooley. The name thalassemia was coined by the Nobel Prize winning pathologist George Whipple and the professor of pediatrics Wm Bradford at […]
- Anemia, pernicious
Anemia, pernicious: Low red blood cell count caused by inadequate vitamin B12. Abbreviated PA. Patients with PA do not produce intrinsic factor (IF), a substance that allows the body to absorb vitamin B12 from foods. The resulting inadequacy of vitamin B12 hampers the production of red blood cells. PA can be treated by injection of […]